Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Eastern Cooperative Oncology Group
Shengjing Hospital
Case Comprehensive Cancer Center
Children's Oncology Group
University of Wisconsin, Madison
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center